Daiichi Wants In On RoxyBond Rival's FDA Challenge
Daiichi Sankyo Inc. on Wednesday asked a Pennsylvania federal judge if it could intercede in a rival's suit challenging the U.S. Food and Drug Administration's approval of abuse-deterrent opioid RoxyBond, saying...To view the full article, register now.
Already a subscriber? Click here to view full article